Kamila Valieva figure skating results will ‘have an asterisk against them’, say IOC

“Would we prefer to have all this not going on? Absolutely. Would we prefer to be having a normal competition

without this happening? I think we would all agree with that.

“My heart goes out to the athletes but we all have to follow the rules and I will not be speculating any more on this specific case.”

However, a succession of skaters – including Team GB’s Natasha McKay – lined up to express their frustration as the IOC find themselves in the unprecedented position of issuing only provisional events for an Olympic competition.

“We respect the opinions of all those great skaters but we have an absolute duty to follow the letter of the law, due process is very, very important,” added Adams.

Kamila Valieva’s controversial coach Eteri Tutberidze watched her compete on Tuesday

“This person has not even had their B sample opened. The case is not even finished yet, so to make all these grand statements is I think a little bit premature.”

Meanwhile, it’s been revealed Valieva had three drugs that are used to treat heart conditions in the sample she gave at the Russian national championships on 25 December.

In addition to the banned angina drug trimetazidine – which her team has claimed is due to a mix-up with her grandfather’s medication – the teen’s sample showed traces of hypoxen and L-Carnitine, though neither are on the banned list.

“She is in the centre of a lot of speculation it must be very tough for her,” added Adams.

Recommended



“We are in touch with the team and her welfare is their first priority and obviously we are very careful of that but there’s only so much that we can do. We all need to be very responsible in the way that we discuss this issue, which has not even been concluded yet.”

Watch All the Olympic Winter Games Beijing 2022 live on discovery+, Eurosport and Eurosport app

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

{{#verifyErrors}} {{message}} {{/verifyErrors}} {{^verifyErrors}} {{message}} {{/verifyErrors}}

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Source: Read Full Article